Sales & Marketing News | pharmaphorum

News

AstraZeneca pledges $400m to fight deforestation

AstraZeneca has said it will plant 200 million trees across six continents by 2030 in an effort to fight escalating rates of deforestation around the globe that is contrib

News

UCB stakes claim to gMG market as FDA clears Rystiggo

The FDA has become the first global regulator to approve UCB’s Rystiggo, a treatment for generalised myasthenia gravis that the company says is the only drug that can be u

News

Lundbeck CEO Deborah Dunsire is stepping down

Lundbeck chief executive Deborah Dunsire has announced her retirement, with a replacement already lined up by the company’s board.

News

Jardiance is first SGLT2 given FDA OK for use in children

With rates of juvenile type 2 diabetes rocketing in the US, doctors now have access to an alternative oral therapy – the first new oral option for more than 20 years.

News

GSK settles first jury trial in Zantac litigation

GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer, rather than proceed with a jury trial.

News

Intercept changes course as OCA is rejected for NASH again

Intercept Pharma has conceded defeat in its battle to get obeticholic acid (OCA) approved as a treatment for non-alcoholic steatohepatitis (NASH) after the FDA rejected it

AstraZeneca pledges $400m to fight deforestation

UCB stakes claim to gMG market as FDA clears Rystiggo

Lundbeck CEO Deborah Dunsire is stepping down

Jardiance is first SGLT2 given FDA OK for use in children

GSK settles first jury trial in Zantac litigation

Intercept changes course as OCA is rejected for NASH again

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks